氯化钾氯化钠注射液

Search documents
港股公告掘金 | 迅销公布前三季度业绩 母公司拥有人应占溢利3390.99亿日圆 同比增长8.4%
Zhi Tong Cai Jing· 2025-07-10 15:11
Major Events - QianShi International (00381) subsidiary FuLao Investment signed a memorandum of understanding with Yanji Municipal Government for potential cooperation in digital economy-related businesses in Hong Kong [1] - Stone Pharmaceutical Group (02005) obtained production registration approval for potassium chloride and sodium chloride injection (500ml and 250ml) [1] - Basilea Pharmaceutica (02616) received approval from the National Medical Products Administration for the domestic production registration application of Prujita® (Pralsetinib capsules) [1] - United BioPharma (03933) received FDA approval for new drug clinical trials for UBT37034 injection [1] - China National Pharmaceutical Group (01177) had the application for the new indication of Kumosil capsules for first-line treatment of breast cancer accepted [1] - Oceanwide Holdings (08476) applied to the Stock Exchange for a transfer listing to the main board [1] Financial Data - Kaison Holdings (00102) reported a loss attributable to shareholders of approximately HKD 740 million for 2023, a shift from profit to loss year-on-year [1] - JiaoGe Friends Holdings (01450) achieved a cumulative GMV of approximately CNY 6.98 billion in the first half of the year, a year-on-year increase of approximately 17.11% [1] - Sunny Optical Technology (02382) reported a smartphone lens shipment of approximately 95.056 million units in June, a month-on-month decrease of 3.1% and a year-on-year decrease of 12.7% [1] - Fast Retailing (06288) announced a profit attributable to the parent company of JPY 339.099 billion for the first three quarters, a year-on-year increase of 8.4% [1] - Jianye Real Estate (00832) reported a total property contract sales of CNY 4.44 billion in the first half of the year, a year-on-year decrease of 1.2% [1] - China Lilang (01234) reported a mid-to-high single-digit year-on-year growth in retail sales of "LILANZ" products in the first half of the year [1]
5月9日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-09 10:22
宜通世纪:中标中国移动通信工程施工服务项目 5月8日晚,宜通世纪(300310)发布公告称,公司中标中国移动2025年至2026年通信工程施工服务(传 输管线)集中采购项目部分标段,中标规模合计2.28亿元(含税)。项目服务内容包括为中国移动广 东、海南、辽宁、四川四省公司提供传输管线施工服务。 资料显示,宜通世纪成立于2001年10月,主营业务是通信网络技术服务、系统解决方案、通信设备生产 销售业务、物联网平台及解决方案、ICT业务。 资料显示,致远新能成立于2014年3月,主营业务为车载LNG供气系统、船用LNG燃料供气系统的研 发、生产和销售。 所属行业:机械设备–通用设备–金属制品 广汽集团:4月汽车销量11.64万辆 同比下降12.66% 5月8日晚,广汽集团(601238)发布公告称,公司4月汽车产量为10.86万辆,同比下降25.74%,本年累 计产量51.98万辆,同比下降5.33%;4月销量为11.64万辆,同比下降12.66%,本年累计销量48.75万辆, 同比下降10.22%。 资料显示,广汽集团成立于1997年6月,主营业务是研发、整车(汽车、摩托车)、零部件、商贸与出 行、能源及生态 ...
哈三联:药品氯化钾氯化钠注射液通过一致性评价
news flash· 2025-05-09 07:49
哈三联(002900)公告,公司药品氯化钾氯化钠注射液通过仿制药质量和疗效一致性评价。该药品用于 治疗各种原因引起的低钾血症、预防低钾血症以及洋地黄中毒引起的心律失常。目前,公司氯化钾氯化 钠注射液三个规格均为国内首家通过一致性评价。这将进一步提升产品的技术水平和市场竞争力。 ...